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Abstract Signaling mechanisms mediated by the Trans-
forming Growth Factor-β (TGF-β) superfamily regulate a
variety of developmental processes. Here we show that
components of both bone morphogenetic protein/growth
differentiation factor and TGF-β/activin/Nodal branches of
TGF-β superfamily signaling are expressed in the developing
subpallium. Furthermore, Smad proteins, transcriptional
effectors ofTGF-β signaling,are co-expressedandphysically
interact in the basal ganglia with Dlx homeodomain tran-
scription factors, which are critical regulators of the differen-
tiation, migration and survival of telencephalic GABAergic
neurons. We also show that Dlx and Smad proteins localize to
promoters/enhancers of a number of common telencephalic
genesin vivo and that Smad proteins co-activate transcription
with Dlx family members, except with certain mutated
human DLX proteins identified in autistic individuals. In
agreement with these observations, expression of dominant-
negative Smads in the developing basal ganglia phenocopies
the cell migration defects observed in Dlx1/2-deficient mice.
Together, these results suggest that TGF-β superfamily
signaling plays a role in telencephalic GABAergic neuron
development through functional interactions with Dlx
transcription factors.
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Introduction
Neurotransmitter subtype specification in the developing
forebrain depends in part on the temporal and spatial
coordinates of local neuronal progenitor/precursor cells.
These coordinates are achieved through the induction of
specific sets of transcription factors in response to a variety
of extrinsic cues. Understanding the intrinsic molecular
mechanisms underlying precursor cell diversity is essential
to understanding the genesis of the forebrain.
In the developing telencephalon, the majority of gamma-
aminobutyric acid (GABA)-ergic interneurons arise from
progenitor zones [ventricular (VZ) and subventricular (SVZ)
zones] within the lateral, medial and caudal ganglionic
eminences (LGE, MGE and CGE, respectively) of the basal
ganglia anlage (subpallium). Newly generated GABAergic
neurons exit the SVZ of these eminences and either radially
migrate into the basal ganglia, where they largely differen-
tiateintoprojectionneurons,ortangentiallymigratetodorsal
structures of the pallium such as the cortex, hippocampus
and olfactory bulb, where they differentiate into different
subclasses of interneurons (Marin and Rubenstein 2003;
Wonders and Anderson 2006; Ayala et al. 2007].
Four members of the mouse Dlx protein family (Dlx1, 2,
5 and 6), part of the Antennapedia class of non-Hox
homeodomain transcription factors, are expressed in the
embryonic subpallium (Panganiban and Rubenstein 2002).
Within this region, their expression overlaps with that of
Gad65 and Gad67, genes encoding different forms of the
rate-limiting enzyme required for production of GABA
from glutamate. In Dlx1/2
−/− double mutant mice, the
tangential migration of GABAergic interneurons into
pallial structures is nearly extinguished and neuronal
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(Anderson et al. 1997a, b, 2001; Yun et al. 2002;L o n g
et al. 2007). These findings show that Dlx function is
essential to the correct differentiation and migration of
GABAergic interneurons.
Currently, little is known about the signaling pathways
that modulate Dlx activity. In that regard, recent studies in
non-neural cells have suggested the existence of functional
interactions between Dlx proteins and Smad transcription
factors, which are critical mediators of transforming growth
factor-β (TGF-β) superfamily signaling pathways (Chiba
et al. 2003; Berghorn et al. 2006). TGF-β superfamily
members, including activin, bone morphogenetic protein
(BMP), growth differentiation factor (GDF), Nodal, and
TGF-β proteins, are secreted molecules that regulate an
array of biological functions in many cell types (Shi and
Massague 2003; Derynck and Zhang 2003; Massague et al.
2005). They act by stimulating specific membrane serine/
threonine receptor complexes, the activin-like kinase
receptors, resulting in the phosphorylation and activation
of regulatory Smads (R-Smads). Smads 1, 5 and 8 are
mainly activated by BMP and GDF receptors, while Smads
2and3aresubstratesforTGF-β,activinandNodalreceptors.
Once activated, R-Smads accumulate in the nucleus where
they associate with Smad4, a common partner for all R-
Smads, to form transcription complexes. R-Smad:Smad4
complexesregulatetranscriptionofavarietyofgenesthrough
recruitment of other transcription factors, including coactiva-
tors or corepressors (Shi and Massague 2003; Derynck and
Zhang 2003; Massague et al. 2005).
Here we describe results that suggest an important role
for TGF-β superfamily signaling in the development of
telencephalic GABAergic neurons. Moreover, we provide
in vivo evidence that Dlx and R-Smad proteins are co-
expressed, physically interact, and localize to Dlx-regulated
enhancers/promoters in the developing subpallium. Our
results show further that Dlx proteins synergistically
activate transcription from the promoter of a Dlx target
gene. Together, these results suggest that TGF-β super-
family signaling and Dlx homeoproteins work together to
promote telencephalic GABAergic neuron development.
Materials and methods
DNA plasmids
The reporter plasmid containing the LacZ gene driven by
the mouse Dlx5/6 intergenic enhancer-i (mI56i-LacZ)
(Zerucha et al. 2000) was provided by Dr. Mark Ekker
(University of Ottawa, Ottawa, ON). Vectors for expression
of FLAG epitope-tagged human DLX2 and DLX5 were
obtained by cloning the complete human cDNA sequences
into pCAGGS/ES, a chicken β-actin promoter expression
vector (Stuhmer et al. 2002a, b), using PCR primers
containing the sequence of the FLAG epitope at the N-
terminus. Expression vectors for the DLX2 (Ser7, Glu-Lys,
and Ala-Thr) and DLX5 (Ser-Pro and Ser-Arg) mutant
proteins identified in autistic patients were obtained using
the QuickChange site-directed mutagenesis kit (Stratagene,
La Jolla, CA). Plasmids pCAGGS-Dlx1 and pCAGGS-GFP
were described elsewhere (Stuhmer et al. 2002a, b).
Plasmids pCMV5B/FLAG-Smad1, pFLAG-Smad2, and
pSmad4-HA (Attisano et al. 1996; Macias-Silva et al.
1996) were gifts from Drs. Jeffrey Wrana and Liliana
Attisano (University of Toronto, Toronto, ON). Dominant
negative mutant forms of Smad1, Smad2 and Smad4
(Zhang et al. 1996, 1998) were provided by Dr. Rik
Derynck (UCSF, San Francisco, CA).
Microarray analysis
RNA was extracted from embryonic stage (E) 15.5 basal
ganglia dissected from either wild type or Dlx1/2
−/−
mutants. Total RNA was isolated using the Absolutely
RNA Miniprep kit (Stratagene). Twenty micrograms of
pooled RNA from each genotype was used. Hybridization
to Affymatrix 430 2.0 microarrays of the amplified and
labeled cDNA was performed by the NIH Neuroscience
Microarray Consortium (http://arrayconsortium.tgen.org/
np2/home.do).
Animal procedures
Animal procedures were conducted in accordance with the
guidelinesoftheCanadianCouncilforAnimalCareandwere
approvedbytheMontrealNeurologicalInstituteAnimalCare
Committee. Pregnant females were anesthetized in a CO2
chamber and euthanized by cervical dislocation. E15.5
embryos were recovered and their brains dissected and
fixed with 4% paraformaldehyde in phosphate-buffered
saline. After fixation, brains were cryoprotected by immer-
sion in 30% sucrose, frozen-embedded in Tissue-Tek O.C.T.
compound (Sakura Finetek U.S.A., Torrance, CA) and
stored at −80°C. Frozen tissues were cryostat sectioned at
20µm and mounted onto SuperFrost Plus slides (Fisher,
Pittsburgh, PA).
In situ hybridization
In situ hybridization experiments were performed using
digoxigenin-labeled riboprobes on frozen sections as
described on the Rubenstein lab website (http://www.ucsf.
edu/jlrrlab/protocols.html), using the following probes:
Dlx2, Gad67 (provided by Dr. Brian Condie, University of
Georgia, Athens, Georgia), Gdf11 (provided by Dr. Alexandra
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York, NY), ActRIIb (provided by Dr. Seung Kim, Stanford
University, Stanford, CA) and BMPR1A (provided by Dr.
Steve Harris, University of Texas Health Science Center at
San Antonio, San Antonio, TX) (Bulfone et al. 1993; Feijen
et al. 1994; Nakashima et al. 1999; Maddox and Condie
2001).
Immunohistochemistry
Analysis of E12.5 and E16.5 frozen sections was performed
as described previously (Marin et al. 2000), except that
sections were heated for 30 min at 60°C in a 10 mM sodium
citrate buffer. The following primary polyclonal antibodies
were used either alone or in combination: rabbit anti-
phosphorylated Smad2 (1:250; Millipore, Billerica, MA;
catalog No. AB3849) and guinea pig anti-Dlx2 (Kuwajima
et al. 2006) (1:5,000; kindly provided by Dr. Kazuaki
Yoshikawa, Osaka University, Osaka, Japan). The following
secondary antibodies were used: Alexa Fluor 488 goat anti-
rabbit IgG (H + L) (1:1000; Invitrogen, Carlsbad, CA;
product No. A-11008), Cy3 AffiniPure F(ab′)2 Fragment
Goat Anti-Guinea Pig IgG (H + L) (1:500, Jackson Immuno-
Research, West Grove, PA; code No. 106-166-003).
Chromatin immunoprecipitation
Cross-linked protein-DNA complexes from dissected E15.5
telencephalon were obtained as described previously (Zhou
et al. 2004). Approximately 1–2×10
7 dissociated cells were
cross-linked with 1% paraformaldehyde for 2 h at room
temperature in the presence of protease inhibitors. Chro-
matin immunopreciptation was then performed using the
Upstate Biotechnology (Millipore) Chromatin Immunopre-
cipitation Assay Kit (Cat. No. 17-295) following the
manufacturer’s instructions. The following antibodies were
used for immunoprecipitation: anti-FLAG M2 (Sigma, St.
Louis, MO, Cat. No. F1804), anti-Dlx2 (Porteus et al.
1994), anti-Smad1 (A-4; Santa Cruz Biotechnology, Santa
Cruz, CA, Cat. No. sc-7965 X), anti-phosphorylated
Smad2 (Millipore; Cat. No. AB3849), anti-phosphorylated
Smad2/3 (Ser 423/425) (Santa Cruz Biotechnology; Cat.
No. sc-11769 X), and anti-Smad4 (C-20; Santa Cruz
Biotechnology; Cat. No. sc-1909 X). The following oligo-
nucleotides were used for polymerase chain reactions: Dlx1/
2-F: 5′-CAGCTG CAAACCCAAGAGGG-3′;D l x 1 / 2 - R :
5′-GCGCAGCAAATTTGGCTTTC-3′; Dlx5/6-F: 5′-
GACATTGGGGA CAATTTAAGG-3′; Dlx5/6-R: 5′-
GCAATTTGTGTAT GAATAAC-3′; Arx-F: 5′-CAAG
CATGTAATTAAGT GAGC-3′; Arx-R: 5′-CCACTGGT
ACAATTGTCAAAT-3′; p21 distal-F: 5′-TATT-
GAATGTCGTGGTGGTGGTGA-3′; p21 distal-R: 5′-
ACAGCACAGCCTCAGGACCCCACT-3′.
Co-immunoprecipitation
For analysis of endogenous proteins, extracts from dissected
E15.5 telencephalon were subjected to immunoprecipitation
using either rabbit anti-phosphorylated Smad2, mouse anti-
FLAG, or rabbit anti-TrkB antibodies (Santa Cruz Bio-
technology) (5 μg each per immunoprecipitation). Each
immunoprecipitation contained 2 mg of tissue extract in
1 ml of Nonidet P-40 lysis buffer (10 mM Tris, pH 8.0,
150 mM NaCl, 1% Nonidet P-40, 10% glycerol) supple-
mented with a protease inhibitor mixture (Roche Products,
Welwyn Garden City, UK). Imunoprecipitates, together with
1% of input lysate, were subjected to Western blotting
analysis with a chicken anti-Dlx2 antibody, a custom-made
affinity-purified antibody raised against a peptide corre-
sponding to amino acids 133 to 146 of mouse Dlx2
(NNEPDKEDLEPEIR) (Aves Lab, Tigard, OR).
Transient transfection/transcription assays
COS cells were transfected using a calcium phosphate
precipitation protocol. In all cases, the total amount of
transfected DNA was adjusted to 2.5µg per well. Assays
were performed with 1.0µg/transfection of reporter construct
mI56i-LacZ in the presence or absence of the effector
plasmids indicated in the figure legends (1.0µg/transfection).
In each case, 0.5μg/transfection of a reporter plasmid
containing the luciferase gene under the control of the RSV
promoter was used as a control for transfection efficiency.
Twenty-four hours after transfection, cells were subjected to
determination of β-galactosidase and luciferase activity as
described (Maira et al. 2003). Results were expressed as
mean values ± S.D.
Organotypic slice culture and electroporation
Preparation of 250µm organotypic slice cultures from
E12.5 forebrains and subsequent electroporation were
performed as described (Stuhmer et al. 2002b). Focal
expression of GFP and/or Smad1, 2 or 4 dominant negative
mutants was achieved by pressure injecting the expression
vectors (5µg/µl) in the MGE or CGE. At least 16 slices
were electroporated with each expression plasmids over 4
independent experiments. Electroporation was performed
using 3 voltage pulses of 75 V with a duration of 5 ms
using a GRASS SD9 stimulator with a 3µF capacitor
placed in parallel to generate exponential decay of current
intensity over time. Slices were photographed using a
fluorescent microscope after 12, 36, 60 and 84 h in order to
detect GFP expression. To monitor the extent of cell death
in the electroporated samples, slices were cultured for 48 h
after electroporation, followed by fixation in 4% parafor-
maldehyde, cryoprotection by immersion in 30% sucrose,
50 J Neurodevelop Disord (2010) 2:48–60and embedding in Tissue-Tek O.C.T. compound. Frozen
slices were cryostat sectioned at 20µm and subjected to
double-label immunofluorescence analysis using mouse
anti-GFP (1:250; Novus Biologicals, Littleton, CO; catalog
number NB-600597) and rabbit anti-active caspase 3 (1:500;
BD Pharmingen, San Diego, CA; catalog number 557035)
antibodies. Grayscale images were digitally adjusted to the
appropriate green or red channels using Northern Eclipse
software (Empix Imaging Inc., Missisauga, ON).
Results
Expression of TGF-β superfamily signaling components
in the developing basal ganglia
A microarray analysis was performed to determine TGF-β
pathway gene expression in the subpallium of E15.5 mouse
embryos. The same analysis was also performed using
Dlx1/2-deficient embryos (results are available at the NIH
Neuroscience Microarray Consortium website http://array
consortium.tgen.org/np2/home.do) (Long et al. 2009). We
found that several components of TGF-β superfamily
signaling were expressed in control embryos (Table 1).
These included members of both the BMP/GDF and TGF-
β/activin/Nodal subfamilies. Most notably, transcripts
expressing the common transcription factor Smad4, as well
as Smad1/5 and Smad2 (from the BMP/GDF or TGF-β
branches, respectively) were present in E15.5 subpallium,
and their expression levels were comparable to those of
Dlx1, 2 and 5. Although the expression of some of those
genes (notably Gdf5/15, ALK-3 and Smad3) was slightly
affected in Dlx1/2
−/− mutants, most of them were un-
changed in mutant embryos, suggesting that expression of
most TGF-β superfamily genes is not downstream of Dlx
function (Table 1).
In situ hybridization experiments using coronal section
through E15.5 mouse telencephalon were performed to
confirm the microarray results and correlate the expression
of selected TGF-β signaling genes to that of genes
expressed in the basal ganglia (Supplemental Fig. 1). Dlx2
expression was detected throughout most of the subpallial
telencephalon, notably in both the LGE and MGE. Within
these structures, Dlx2 was strongly expressed in the
progenitor domains comprising both the VZ and the SVZ
(Supplemental Fig. 1A–D). As previously reported
(Stuhmer et al. 2002a, b), Gad67 expression closely
resembled that of Dlx2, except that it was observed mostly
in the SVZ and mantle zone (where postmitotic neurons are
located) of the LGE and MGE (Supplemental Fig. 1E–H).
Expression analysis of representative members of the BMP/
GDF signaling pathways, including ligands (Gdf11) and
receptors (ActRIIb and BMPR1A), revealed overlapping
expression with Dlx2 and Gad67 within the subpallium.
ActRIIb and BMPR1A were strongly expressed in both the
VZ and SVZ of the MGE and LGE (Supplemental
Fig. 1M–T), similar to the Dlx2 subpallial expression. By
contrast, Gdf11 was mainly expressed in the SVZ of the
LGE and MGE, similar to the expression of Gad67
(Supplemental Fig. 1I–L).
Table 1 Microarray analysis of the expression of TGF-β superfamily
components in the developing subpallium
Value WT Value Dlx1/2
−/−
A) BMP/GDF→ALK 1/2/3/6→Smad 1/5/8 pathway
Ligand Gdfl0 63 55
Gdfl1 57 38
Gdfl5 56 16
Gdf2 46 35
Gdf3 46 20
Gdf9 42 44
Gdf5 30 12
Receptor BMP-RIA (ALK-3) 300 491
ActRI (ALK-2) 281 235
ActRII 236 254
ActRIIB 230 248
BMP-RIB (ALK-6) 74 76
BMPRII 82 93
Smad Smad4 2060 1837
Smad1 711 729
Smad5 239 205
Smad7 44 67
B) TGF-β/activin Nodal→ALK4/5/7→Smad 2/3 pathway
Ligand TGFβ1 108 81
TGFβ25 9 7 6
TGFβ33 8 1 3
Receptor TGFβ-RI (ALK-5) 638 706
TGFβ-RII 36 25
ActRII 236 254
ActRIIB 230 248
Smad Smad4 2060 1837
Smad2 283 337
Smad3 58 14
Smad7 44 67
C) Dlx transcription factors
Dlx Dlx1 1237 15
Dlx2 287 8
Dlx5 706 71
Dlx6 140 20
Microarray gene expression analysis in the subpallium of E15.5 wild
type and Dlx1/2
−/− mutants. Shown are genes of the BMP/GDF (A)
and TGF-β/activin/Nodal (B) subfamilies. Each TGF-β superfamily
member whose expression value was greater than 30 was included
(genes expressed at values >30 are generally detectable by in situ
hybridization) (Long et al. 2009). C, analysis of Dlx gene expression.
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developing mouse basal ganglia, we subjected brain coronal
sections to immunohistochemistry with antibodies against
activated Smad2 (phosphorylated at serines 465 and 467).
At both E12.5 (Fig. 1A–D; Supplemental Fig. 2) and E16.5
(Fig. 1E–K), phosphorylated Smad2 (pSmad2) immunore-
activity was observed in the LGE, MGE, and CGE, where it
localized mostly to the VZ and SVZ, with less robust but
detectable expression in the mantle zone. Importantly, we
observed co-expression of pSmad2 and Dlx2, detected
using a previously described anti-Dlx2 antibody (Kuwajima
et al. 2006), in those regions (Fig. 1C, G, and K,).
Moreover, small numbers of cells co-expressing pSmad2
and Dlx2 were also observed in the lateral neocortex, along
the trajectory normally occupied by tangentially migrating
Dlx2-positive GABAergic neurons (Fig. 1D and K).
Together, these findings provide evidence that the TGF-β
superfamily pathway is activated in precursor cells and
immature neurons of the subcortical telencephalon that also
express Dlx proteins.
Functional interaction between Dlx and Smad
transcription factors
Previous studies have suggested that Dlx and Smad
proteins interact in non-neural cells (Chiba et al. 2003;
Berghorn et al. 2006). Based on our finding that Dlx and
activated Smad expression overlaps in the developing basal
ganglia, we tested if Smad factors might interact with Dlx
homeoproteins in the developing telencephalon. E15.5
mouse embryo telencephalic extracts were subjected to
immunoprecipitation with either anti-phosphorylated
Smad2 or control antibodies, followed by Western blotting
analysis with anti-Dlx2 antibodies. These studies showed
that endogenous Dlx2 was co-immunoprecipitated with
activated Smad2 (Fig. 2A, lane 4), but not when control
antibodies were used (Fig. 2A, lanes 2 and 3). These results
show that Dlx2 and activated Smad2 interact in vivo.
To determine whether Dlx5 can also interact with
Smad2, co-immunoprecipitation studies were performed
using extracts from COS cells transfected with constructs
encoding epitope-tagged FLAG-Smad2 or HA-Smad4 in
combination with FLAG-tagged human DLX5 (throughout
this paper, “Dlx” is used to refer to mouse proteins and
“DLX” to indicate human proteins). Immunoprecipitations
using a rabbit antibody raised against DLX5 revealed that
Smad2 co-immunoprecipitated with DLX5 (Supplemental
Fig. 3). In agreement with previous reports (Chiba et al.
2003; Berghorn et al. 2006), no interaction between Smad4
and DLX5 was detected (Supplemental Fig. 3).
Chromatin immunoprecipitation studies using E15.5
telencephalon were performed next to determine whether
both Dlx and Smad proteins would localize in vivo to the
regulatory regions of genes regulated by Dlx factors
(Zerucha et al. 2000; Ghanem et al. 2007; Colasante et al.
2008; Potter et al. 2009). Using a panel of different anti-
Smad antibodies and previously characterized Dlx2 anti-
bodies (Zhou et al. 2004; Porteus et al. 1994), we found that
Dlx2, Smad1, Smad2/3, and Smad4 were associated with
the Dlx1/2, Dlx5/6 and Arx enhancers in the E15.5
telencephalon (Fig. 2B).
Transient transfection assays were then conducted to
determine whether Dlx and Smad proteins would regulate
together transcription from a telencephalic enhancer. COS
cells were transfected with a plasmid containing a LacZ
reporter gene under the control of the Dlx5/6 intergenic
enhancer (Zerucha et al. 2000) in combination with various
DLX and/or Smad expression plasmids. DLX2, and also
DLX1 and DLX5, activated transcription of the reporter
gene 5–10 fold (Fig. 2C). Expression of Smad1, Smad2 or
Smad4 alone had no significant effect on reporter gene
expression, suggesting that Smad transcription factors do
not directly bind the Dlx5/6 enhancer or that they require
the presence of transcriptional partners to activate tran-
scription upon binding. However, when co-expressed in
combination with DLX5, DLX2, and to a lesser degree
DLX1, both Smad1 and Smad2 significantly enhanced
DLX-dependent transcriptional activation, whereas Smad4
had little or no effect (Fig. 2C). We observed no increased
DLX affinity for DNA in the presence of Smad in
electrophoretic mobility shift assays (data not shown).
Taken together, these results indicate that Smad and Dlx
proteins are co-expressed and interact in cells of the
developing telencephalon. Moreover, they localize to
enhancer/promoters of telencephalic genes in vivo, and
can co-operatively activate transcription. These findings
provide evidence that Smad and Dlx proteins functionally
interact to promote activation of telencephalic gene expres-
sion in vivo.
Distinct effects of naturally occurring DLX mutations
from autistic patients on Smad-dependent potentiation
of DLX transcriptional activity
Previous evidence suggests a role for DLX proteins in
human neuropsychiatry disorders, such as autism. For
instance, mice lacking Dlx1 exhibit loss of subsets of local
cortical circuit neurons and develop epilepsy, a malady
commonly seen in the autistic population (Cobos et al.
2005). In addition, the human DLX bigene clusters are
located on chromosomes 2q31.1 (DLX 1/2) and 7q21 (DLX
5/6), which are both autism susceptibility loci as deter-
mined by independent linkage studies (Consortium
IMGSoA 2001; Bacchelli et al. 2003; Hutcheson et al.
2003). Furthermore, sequencing of DLX genes in autistic
patients and non-autistic siblings led to the identification of
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Lys”, and “Ala-Thr”) and two in DLX5 (“Ser-Pro” and
“Ser-Arg”) in autistic individuals (Hamilton et al. 2005)
(Fig. 3A).
To determine whether the DLX2 and/or DLX5 mutations
characterized in autistic patients might affect the interaction
between Smad and DLX proteins, we introduced those
mutations into the human DLX2 or DLX5 cDNA sequences
Fig. 1 Co-expression of activated Smad2 and Dlx2 in the developing
basal ganglia. A–D, Double-labeling immunofluorescence analysis of
the expression of phosphorylated Smad2 (pSmad2) (A) and Dlx2 (B)
in coronal hemisections of E12.5 forebrain at caudal telencephalic
level. C, Merged pSmad2 and Dlx2 staining: overlapping expression
(yellow color) is visible in many cells in the CGE (large rectangle). D,
High-magnification view of the area enclosed by the small rectangle in
(C): arrowheads point to cells co-expressing pSmad2 and Dlx2 in the
neocortex. E–K, Expression of pSmad2 (E, H and I) and Dlx2 (F and
J) in coronal hemisections of E16.5 telencephalon at rostral (E–G)o r
mid-telencephalic (H–K) positions. Merged staining is shown in (G
and K). I–K, High-magnification views of the boxed area in (H).
Overlapping expression of pSmad2 and Dlx2 was detected in the LGE
and MGE, as well as in migrating GABAergic neurons in the
neocortex (arrowheads in panel K). CGE, caudal ganglionic eminence;
Cx, neocortex; IZ, intermediate zone; LGE, lateral ganglionic
eminence; LV, lateral ventricle; MGE, medial ganglionic eminence;
Se, septum
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exhibited similar expression levels when transfected in
COS cells (Fig. 3B). Moreover, in dose-dependent transient
transfection/transcription assays, all DLX2 and DLX5
mutants retained the ability to activate transcription
(Supplemental Fig. 4A). The DLX2 mutants exhibited a
trend towards a stronger transcriptional activity than wild
type DLX2, but this was not statistically significant. EMSA
analysis indicated no alteration in DNA binding for any of
the DLX mutants (Supplemental Fig. 4B).
The transcriptional activity of the DLX2 mutants was
enhanced by Smad1 and Smad2, similarly to wild-type
proteins (Fig. 3C). By contrast, both DLX5 mutants
exhibited impaired functional interaction with Smad fac-
tors. More specifically, the transcriptional activity of the
DLX5 Ser-Pro mutant was not potentiated by either Smad1
or Smad2, while the DLX5 mutant Ser-Arg was not
responsive to Smad2-mediated transcriptional potentiation
(Fig. 3C). Together, these results suggest that DLX
mutations identified in autistic patients do not perturb
DLX DNA binding and transcriptional activity but have
different effects on DLX:Smad interactions.
Inhibition of tangential cell migration from the basal
ganglia to the cortex by blockage of TGF-β superfamily
signaling
Dlx genes are essential for the proper migration of
GABAergic interneurons from the subpallial SVZ to the
neocortex (Anderson et al. 1997a, b, 2001). Smad and Dlx
proteins are co-expressed in the basal ganglia and in cells
located in the lateral neocortex, likely corresponding to
tangentially migrating GABAergic neurons (Fig. 1). More-
over, Smad and Dlx proteins interact in the developing
telencephalon and localize to common DNA sequences in
vivo (Fig. 2). Based on these observations, we examined
Fig. 2 Physical and functional interaction between Dlx and Smad
transcription factors. A, In vivo co-immunoprecipitation. Extracts
obtained from dissected E15.5 telencephalon were subjected to
immunoprecipitation with anti-phosphorylated Smad2 (lane 4) or
control (lane 2 and 3) antibodies, as indicated. Immunoprecipitates,
together with 1% of input lysate (lane 1), were subjected to Western
blotting with a chicken anti-Dlx2 antibody. The position of migration
of the immunoglobulin light chain (IgG LC) is indicated. B,
Chromatin immunoprecipitation. Protein-DNA complexes from dis-
sected E15.5 telencephalon were subjected to immunoprecipitation
with the indicated antibodies, followed by PCR with oligonucleotide
primers specific for the Dlx1/2, Dlx5/6 and Arx enhancers or the
p21
Cip1 distal promoter. Dlx2, Smad1, Smad2/3, and Smad4 were
associated with the Dlx1/2, Dlx5/6 and Arx enhancers, but not with the
distal region of the p21
Cip1 promoter. Total genomic DNAwas used as
a positive control (Input). C, Transient transcription assays. The effect
of Smad1, Smad2 or Smad4 on Dlx1-, Dlx2- and Dlx5-mediated
transcriptional activity was assessed by co-transfecting COS cells with
a LacZ reporter plasmid driven by the Dlx5/6 enhancer-i (mI56i-
LacZ). Results are shown relative to the activity of the reporter alone
and represent the means ± the S.D. of at least four experiments
performed in duplicates (*, p<0.05 using one-way analysis of
variance with a Dunnett’s post test). A reporter plasmid containing
the luciferase gene under the control of the RSV promoter was used as
a control for transfection efficiency
b
54 J Neurodevelop Disord (2010) 2:48–60whether TGF-β signaling is involved in GABAergic
interneuron development. More specifically, we tested if
inhibition of TGF-β signaling in the embryonic subcortical
telencephalon would phenocopy the accumulation of
immature interneurons in the SVZ of the MGE and CGE
observed in Dlx1/2 null mutants. Organotypic slices from
the brain of wild-type E12.5 mouse embryos were prepared
from different levels of the rostro-caudal axis and focally
electroporated in the VZ/SVZ of the MGE or CGE with a
combination of dominant-negative Smad mutants (Smad-
DN) and GFP expression vectors. Controls involved
electroporation of GFP alone (‘control side’). Slices were
then cultured and the tangential migration of the electro-
porated cells was monitored 12, 36, 60 and 84 h after
electroporation.
To interfere with both branches of TGF-β superfamily
signaling, organotypic slices were electroporated with a
previously described (Zhang et al. 1996, 1998) dominant-
negative form of Smad4 (the obligatory partner for all R-
Smads). Compared to exogenous expression of GFP alone,
expression of Smad4-DN in the MGE or CGE completely
abrogated the tangential migration of the electroporated
cells to the cortex (Fig. 4). Forced expression of Smad4-DN
did not cause a notable increase in cell death, detected using
an antibody against active caspase 3 (Supplemental Fig. 5).
This result suggests that the impaired tangential migration
caused by the expression of Smad4-DN was not the result
of decreased survival of the electroporated cells. Similar
experiments were performed using dominant-negative
forms of Smad1 and Smad2 (Zhang et al. 1996, 1998)t o
specifically block either BMP/GDF subfamily or TGF-β/
activin/Nodal subfamily signaling, respectively. Expression
of both Smad1-DN and Smad2-DN in the MGE or CGE
also resulted in impaired tangential migration, compared to
control conditions (Fig. 5). Each dominant-negative form
alone had a weaker effect than Smad4-DN, consistent with
only a partial inhibition of TGF-β superfamily signaling in
either case. Taken together with the results depicted in
Figs. 1 and 2, these findings provide evidence that TGF-β
superfamily signaling is important for neuronal cell migra-
tion from the subpallium to the cortex. Moreover, they
suggest the existence of a functional interaction between
Dlx and TGF-β signaling pathways in the regulation of
telencephalic GABAergic neuron development.
Discussion
Using a combination of expression studies and ex vivo
electroporation assays, we provided evidence that both
branches of TGF-β signaling are active in developing
ganglionic eminences and that dominant-negative inhibition
of Smad activity in the basal ganglia impairs tangential
Fig. 3 Effect of Smad proteins on the transcriptional activity of
mutated DLX proteins found in autistic individuals. A, Schematic
representation of the location of the DLX2 and DLX5 mutations
identified in autistic individuals. Note that all mutations occur in
regions of homology between DLX proteins. The DLX2 serine
insertion (Ser7) is in the DllA domain conserved in the DLX2/3/5
subgroup (green boxes), the DLX2 glutamic acid to lysine (Glu-Lys)
mutation is in a conserved region flanking the homeodomain of the
DLX2/3/5 subgroup (blue boxes), while the DLX2 alanine to
threonine (Ala-Thr) and both DLX5 serine to proline (Ser-Pro) and
serine to arginine (Ser-Arg) mutations occur in a proline-rich domain
conserved in all six mammalian DLX proteins (yellow boxes). B,
Expression of wild type (WT) and mutant DLX proteins. COS cells
were transfected with plasmids expressing the indicated proteins,
followed by Western blot analysis with an anti-FLAG antibody. C,
Transient transcription assays. COS cells were transfected with a LacZ
reporter plasmid driven by the Dlx5/6 enhancer-i in the absence or
presence of the indicated combinations of proteins. All DLX2 mutants
behaved like wild type DLX2 in these assays in the absence or
presence of Smad proteins. By contrast, Smad co-expression did not
enhance DLX5 Ser-Pro-mediated transcriptional activity, while the
DLX5 Ser-Arg mutant exhibited an impaired transcriptional interac-
tion with Smad2. Results are shown relative to the activity of the
reporter alone and represent the means ± the S.D. of at least four
experiments performed in duplicates (*, p<0.05 using one-way
analysis of variance with a Dunnett’s post test)
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demonstration that blocking Smad signaling phenocopies
the GABAergic interneuron migration defect observed in
Dlx1/2-deficient mice, we also demonstrated that Dlx and
Smad proteins are co-expressed, interact, and localize to
common gene regulatory sequences in the developing
telencephalon. Moreover, they co-activate transcription
from a telencephalic enhancer in vitro.T h e s er e s u l t s
suggest a cross-talk between TGF-β signaling and Dlx
proteins during development of telencephalic GABAergic
neurons.
Activation of TGF-β signaling in the developing
basal ganglia
TGF-β signaling pathways perform critical roles during a
variety of developmental processes, including functions
important for brain patterning and differentiation (Liem et
al. 1997; Crossley et al. 2001; Panchision et al. 2001;
Hebert et al. 2002, 2003; Seoane et al. 2004; Fernandes et
al. 2007). Several previous studies suggest roles for TGF-β
signaling in dorsal forebrain development. For instance,
Bmp2/4/5/6/7 are expressed in the embryonic dorsomedial
telencephalon, a region that gives rise to the cortical hem
and the choroid plexus. In this region, those BMP proteins
induce Msx1 and repress Foxg1 gene expression, thus
inhibiting progenitor cell proliferation (Furuta et al. 1997;
Shimamura and Rubenstein 1997; Ohkubo et al. 2002). A
role for BMP signaling in the dorsal telencephalon is also
suggested by the conditional mutation of BMP receptors,
which results in loss of the choroid plexus (Hebert et al.
2002, 2003; Fernandes et al. 2007). In contrast, relatively
little is known about the role of the TGF-β pathway during
development of the basal ganglia and GABAergic neurons.
To begin to determine whether TGF-β superfamily
signaling is important for the development of the sub-
pallium, we analyzed the basal ganglia RNA expression of
components from both TGF-β signaling sub-pathways,
including ligands, receptors and Smad transcription factors.
Our findings show that genes encoding several TGF-β
Fig. 4 Role for TGF-β signaling in tangential migration of GABAergic
interneurons in the developing telencephalon. Organotypic cultures of
E12.5 forebrain slices from different levels of the rostrocaudal axis were
focally electroporated into the MGE or CGE with a GFP expression
vector alone (left hemisphere; panels a-l) or with a combination of GFP
and dominant-negative Smad4 (Smad4-DN) (right hemisphere; shown
in each case in panels a′-l′). Slices were photographed after 12, 36, 60
and 84 h to visualize the tangential migration of GFP-expressing (i.e.,
electroporated)cellsawayfromtheMGEorCGE.Asignificantdecrease
of cell migration towards the neocortex was observed in the hemisphere
electroporated with Smad4-DN
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basal ganglia. This observation extends previous reports
describing the forebrain expression of certain members of
this secreted protein family, including Bmp7 (Tole et al.
2000), Bmp9 (Lopez-Coviella et al. 2006), and Bmp2/4/6
(Hattori et al. 1999; Gratacos et al. 2002). Our results also
show that type I and type II receptors for both TGF-β sub-
pathways are expressed in the subpallium. This finding
confirms previous reports showing that most BMP/GDF
subfamily receptors are detected in the developing basal
ganglia (Lopez-Coviella et al. 2006; Hattori et al. 1999;
Gratacos et al. 2002). We also detected expression of
Smad1, Smad5, Smad2, as well as Smad4, in the subpal-
lium, where they exhibit expression levels similar to those
of the Dlx genes. In contrast, Smad3 and Smad7 appear to
be only weakly expressed in the basal ganglia. Similar
observations were made in septum-derived cells, albeit at
different developmental stages (Lopez-Coviella et al. 2006).
We showed further that phosphorylated (activated)
Smad1 (data not shown) and Smad2 (this study) are present
in the developing basal ganglia. Importantly, phosphorylated
Smad2 expression exhibits a regional and cellular overlap
with Dlx2 expression in the subpallium, suggesting that
Smad2 is activated in developing telencephalic GABAergic
neuronal precursors that express Dlx2 (Anderson et al. 2001;
Eisenstat et al. 1999). Certain Dlx2-positive cells did not
appear to express activated Smad2. This observation could
be due to the fact that activated Smad3 and/or Smad1/5
might be expressed in those cells and play a role similar to
that of phosphorylated Smad2. Alternatively, Smad2 might
not be phosphorylated in all cells expressing Dlx2. Impor-
tantly, we also observed the presence of cells co-expressing
phosphorylated Smad2 and Dlx2 in the neocortex, likely
corresponding to tangentially migrating interneurons, sug-
gesting an involvement of TGF-β signaling in tangential
interneuron migration. Together, these findings correlate
activated Smad2 expression with sequential stages of
telencephalic GABAergic neuronal development.
Functional interaction between Dlx and Smad
transcription factors
Prior to the present study, little was known about the
molecular mechanisms underlying Dlx activity during basal
ganglia development. Previous information was limited to
the observation that Dlx and Msx1/Msx2 homeoproteins
interact to mediate a mutual inhibition of their DNA
binding activities and transcriptional functions (Panganiban
Fig. 5 Role for both branches of TGF-β signaling in tangential
migration of GABAergic interneurons in the developing telencephalon.
Organotypic cultures of E12.5 forebrain slices from different levels of
the rostrocaudal axis were focally electroporated into the MGE or CGE
with a GFP expression vector alone (left hemisphere; panels a-l) or with
a combination of GFP and dominant-negative Smad1 (Smad1-DN) (A)
or dominant negative Smad2 (Smad2-DN) (B) (right hemisphere;
shown in each case in panels a′-l′). Slices were photographed after 12,
36, 60 and 84 h to visualize the tangential migration of GFP-
expressing cells from the MGE or CGE. Decreased cell migration
towards the neocortex was observed in the hemisphere electroporated
with dominant-negative Smad forms
J Neurodevelop Disord (2010) 2:48–60 57and Rubenstein 2002; Zhang et al. 1997). In the present
study, we tested the possibility of a cross-talk during basal
ganglia development between Dlx and TGF-β pathways
based on the overlapping expression of Dlx and activated
Smad proteins in the subpallium and the observation that
certain Dlx and Smad family members interact in non-
neural cells (Chiba et al. 2003; Berghorn et al. 2006). Using
both in vivo protein-protein interaction studies and tran-
scription assays in transfected cells, we found that Smad
transcription factors physically interact, and co-activate
transcription from a telencephalic enhancer, with Dlx
proteins. Moreover, chromatin immunoprecipitation studies
showed the in vivo localization of both Dlx and Smad
proteins to a number of telencephalic enhancers/promoters
that are known to be dependent on Dlx1/2 function
(Zerucha et al. 2000; Ghanem et al. 2007; Colasante et al.
2008; Potter et al. 2009). These findings strongly suggest
that Smad and Dlx proteins participate in common
mechanisms during subcortical telencephalon development,
shedding new light into the molecular events underlying
Dlx function during forebrain development.
Our finding that Dlx1/2/5 and Smad1/2 co-operate to
promote transcriptional activation from the enhancer of a
telencephalic gene does not appear to result from an
increased affinity (or stabilization) of Dlx binding to its
DNA target element. EMSA experiments performed using a
probe containing a Dlx-binding motif from the mouse Dlx5/
6 enhancer-i (Zhou et al. 2004) showed that Dlx DNA
binding was not affected by co-expression of Smad1,
Smad2 or Smad4 (data not shown). It is possible that
enhancement of Dlx-mediated transactivation by Smad is
the result of a more efficient recruitment of transcriptional
co-activators. Potential Dlx co-activators include the PDZ
protein, GRIP1 (Yu et al. 2001), Dlxin-1 (Masuda et al.
2001), and Necdin (Kuwajima et al. 2006), while CBP/
p300 transcription factors are believed to be co-activators
for Smads (Feng et al. 1998; Janknecht et al. 1998). It
should be noted that our observation of a transcriptional co-
operation between Dlx and Smad proteins on a telence-
phalic promoter is in contrast with studies showing that
Dlx1/Smad4 and Dlx3/Smad6 interactions result in antag-
onistic transcriptional effects in non-neural cells (Chiba et
al. 2003; Berghorn et al. 2006). For instance, previous
studies suggested that Dlx1 interferes with TGF-β path-
ways by binding to Smad4 and sequestering transcriptional
co-activators from Smad3/Smad4 heterodimers (Chiba et al.
2003). This discrepancy might be explained by different
promoter/enhancer contexts and/or contrasting molecular
properties of different Dlx/Smad complexes.
Protein phosphorylation might represent an additional
mechanism modulating Smad/Dlx cross-talk. BMP2 stimu-
lation of osteoblasts elicits the phosphorylation of Dlx5 by
the p38 kinase pathway (Ulsamer et al. 2007). Given that
Smads are known to be regulated by various kinase
pathways (Massague et al. 2005), including p38 signaling,
it is possible that a single extracellular stimulus might
regulate the phosphorylation state of both Dlx and Smad
proteins and thus synchronously regulate their transcrip-
tional activity. In this regard, our observation that Smad
proteins did not enhance transactivation mediated by the
DLX5 Ser-Pro and Ser-Arg mutants identified in autistic
individuals is intriguing given that serine residues are
affected in each case. Future studies are needed to test
whether those serines might be kinase substrates. It is also
plausible that DLX5 mutants/Smad heteromers fail to
recruit the appropriate co-activators.
Role for TGF-β signaling in telencephalic GABAergic
neuron differentiation
The functional interaction between Dlx and Smads, in
addition to the similarities in the expression pattern of Dlx2
and activated Smad2, as well as Gad67 and various
components of TGF-β pathways, suggested a role for
TGF-β signaling in GABAergic neuron differentiation.
We tested this possibility by performing ex vivo loss of
function studies based on the electroporation of dominant
negative forms of Smad1, Smad2, and Smad4 in organo-
typic brain slices. Expression of those dominant negative
mutants in the developing basal ganglia phenocopied the
defects in tangential migration observed in Dlx1/2-deficient
mice. Smad1 and Smad2 dominant negative mutants
partially blocked tangential neuron migration, whereas
inhibition of Smad4 nearly completely blocked migration.
These results suggest that both the BMP/GDF and TGF-β/
activin/Nodal pathways play a role in that process, resulting
in a partial functional redundancy between sub-pathways.
A role for TGF-β signaling in GABAergic neuron dif-
ferentiation is in agreement with the observation that BMP2
promotes survival and differentiation of cultured striatal
GABAergic neurons (Hattori et al. 1999) and that BMP6 is
a neurotrophic factor for calbindin-positive (GABAergic)
striatal neurons (Gratacos et al. 2002). TGF-β signaling
might also be implicated in the differentiation of other
neuronal subtypes in the basal ganglia. This has been
postulated for BMP9, which is expressed in the developing
striatum and appears to regulate cholinergic neuron differ-
entiation (López-Coviella et al. 2002). It is also worth
noting that there is evidence that BMPs regulate expression
of Dlx2 and Dlx5 during bone and feather bud development
(Luo et al. 2001; Harris et al. 2003; Kim et al. 2004;
Rouzankina et al. 2004; Levi et al. 2006; Liu et al. 2007).
While Dlx function may not strongly regulate expression of
TGF-β signaling components in the embryonic mouse basal
ganglia, we cannot rule out that Dlx transcription factors
regulate these genes in other tissues.
58 J Neurodevelop Disord (2010) 2:48–60In conclusion, the characterization of a functional
interaction between Dlx proteins and TGF-β signaling
pathways is expected to provide new insight into the
regulation of the expression of GABAergic phenotype-
specific genes. It will also facilitate the characterization of a
number of other developmental mechanisms where the
expression of members of these protein families overlaps.
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